Navigation Links
Multiple Vimpat(R) (lacosamide) Studies Presented at American Epilepsy Society Annual Meeting
Date:12/8/2008

t(R) appeared to provide a similar magnitude of seizure reduction versus placebo regardless of which AED was included as part of the patients' baseline treatment regimen, which included one to three concomitant AEDs:

    -- Carbamazepine (36.5 percent seizure frequency reduction with Vimpat(R)
       400 mg/day vs. 21.7 percent with placebo)
    -- Lamotrigine (33.3 percent vs. 18.3 percent)
    -- Levetiracetam (37.6 percent vs. 17.6 percent)
    -- Valproate (45.3 percent vs. 21.3 percent)
    -- Topiramate (41.4 percent vs. 28.5 percent)
    -- Oxcarbazepine (27.2 percent vs. 12.5 percent)

Similar results were seen for responder rates (patients with 50 percent or greater reduction in seizure frequency):

    -- Carbamazepine (37.4 percent responder rate with Vimpat(R) 400 mg/day
       vs. 26.4 percent placebo)
    -- Lamotrigine (34.2 percent vs. 19.0 percent)
    -- Levetiracetam (43.4 percent vs. 19.4 percent)
    -- Valproate (47.5 percent vs. 26.9 percent)
    -- Topiramate (41.9 percent vs. 25.6 percent)
    -- Oxcarbazepine (29.7 percent vs. 17.6 percent)

Poster Session 3, December 8, 2008, 8:00 - 9:00 am (Poster 3.246)

William Rosenfeld, MD, David Rudd, PharmD, David Hebert, PhD, Pamela Doty, PhD

The Comprehensive Epilepsy Care Center for Children and Adults, St. Louis, Missouri

Schwarz Biosciences Inc. (a member of the UCB Group), Raleigh, NC, USA

Safety and Tolerability of Lacosamide: A Summary of Adverse Events in Epilepsy Clinical Trials

This pooled analysis clinical trial safety data showed Vimpat(R) to be generally well-tolerated, although 85 percent of trial participants were already taking two to three concomitant AEDs upon trial entry:

-- The most frequently reported individual treatment emergent adverse events (TEAE) occurring in greater than or equal to 10 percent of the Vimpat(
'/>"/>

SOURCE UCB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Genomic Health to Present Multiple New Studies at 31st Annual San Antonio Breast Cancer Symposium
2. Derma Sciences Announces Multiple Clinical Posters Featuring MEDIHONEY(R) and ALGICELL Ag(R) to be Presented at Upcoming Wound Care Conference
3. TorreyPines Therapeutics Begins Dosing in a Phase I Multiple Dose Clinical Trial of NGX426, Oral Prodrug of Tezampanel
4. Senescos Preclinical Multiple Myeloma Data to be Presented at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
5. Bolder BioTechnology Receives $1.6 million NIH Grant to Continue Development of Multiple Sclerosis Drug
6. Environmental Tectonics Corporation Announces a Multiple Sale of Hyperbaric Monoplace Chambers to Comprehensive Healthcare Solutions
7. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
9. Orexigen Therapeutics Announces Multiple Data Presentations at The Obesity Society Annual Scientific Meeting
10. Memory Pharmaceuticals Completes Phase 1 Multiple Ascending Dose Study of R4996/MEM 63908
11. Environmental Tectonics Corporation Announces a Multiple Sale for Monoplace Hyperbaric Chambers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... (PRWEB) March 26, 2015 ReliantHeart, Inc., ... and Transonic, a supplier of precision transit-time flow measurement ... will greatly improve the efficiency of the HeartAssist5® ... LVAD patients to experience greater mobility and peace of ... the miniature flow board, will draw 1/6th of the ...
(Date:3/25/2015)... one of the most attractive in the emerging European ... growing economy and increasing government investment in healthcare, according ... market is set to grow at twice the pace ... 10-15% annually reaching an approximate market value of $43-60 ... Green Cross provides total healthcare solutions that address ...
(Date:3/25/2015)... 25, 2015 The surging prevalence ... have fuelled social media growth, with over 50% ... in social networking. Insurance companies are making use ... clients and promote a diversity of their services ... increasingly exploiting social networking services as part of ...
(Date:3/25/2015)... and REYKJAVIK, Iceland , March ... for using the genome to create better medicine, today congratulated ... largest studies of whole-genome data yet undertaken. ... Genetics – are built around the most comprehensive ... team of deCODE scientists led by Kari Stefansson , ...
Breaking Biology Technology:LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 2LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 3Social Media Role in Global Insurance Industry Examined by Timetric in New Market Research Report Published at MarketPublishers.com 2Social Media Role in Global Insurance Industry Examined by Timetric in New Market Research Report Published at MarketPublishers.com 3Landmark deCODE Studies Demonstrate the Power of Truly Big Genomics for Improving Medicine Worldwide 2
... Society of Forensic Toxicologists (SOFT) recognizes the recent ... Strengthening Forensic Science in the United States: A ... within the forensic sciences where improvements may be ... education, training, accreditation and certification in forensic science. ...
... superior to synthetic HRT with greater cardiovascular benefits ... 23 The most comprehensive analysis to date, ... peer-reviewed publication for practicing clinicians, showed that bioidentical ... are more efficacious than their synthetic counterparts. Conducted ...
... BOZEN, Italy, February 23 Health Robotics ... a definitive agreement whereby Can-Med,has acquired the ... in Armenia, Georgia, Kazakhstan, Uzbekistan, Azerbaijan,Iran, Mongolia, ... first and only automated, point-of-care-distributed, and fail-safe,robotic ...
Cached Biology Technology:The Society of Forensic Toxicologists Comments on the National Academy of Sciences' Report on 'Strengthening Forensic Science in the United States' 2New Analysis Finds Bioidentical Hormones Safer Than Standard Hormone Replacement Therapy 2New Analysis Finds Bioidentical Hormones Safer Than Standard Hormone Replacement Therapy 3Health Robotics Expands i.v.STATION(TM) Partnership With Can-Med in 10 Countries Within Central Asia 2Health Robotics Expands i.v.STATION(TM) Partnership With Can-Med in 10 Countries Within Central Asia 3
(Date:3/11/2015)... Research and Markets ( http://www.researchandmarkets.com/research/3p32qm/access_control ) ... Market by Product, Application & By Geography - Global ... offering. , This report predicts that the ... by 2020, with an estimated CAGR of 10.6%. ... types such as contact cards & readers, contactless cards ...
(Date:3/10/2015)... , March 10, 2015  NXT-ID, Inc. ... or the "Company"), a biometric authentication company focused ... company,s Wocket™ smart wallet has been named the ... Rethink Modern. Rethink Modern ( http://www.rethinkmodern.com/ ... innovative items for your home and lifestyle that have a ...
(Date:3/2/2015)... HUNTSVILLE, Ala. , March 2, 2015 /PRNewswire/ ... transaction processing. Data protection company Tharon Rankins Enterprises ... product that provides an ultra-safe way for businesses ... as their financial transactions. Beconux ... by Tharon Rankins Enterprises. Functioning similarly to an ...
Breaking Biology News(10 mins):Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 3NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 4Personal Data Protection Company Launches New Product 2
... , July 25, 2013 The following statement is being issued by ... regarding the Pacific Biosciences Securities Litigation SUPERIOR COURT OF THE ... MATEO IN RE PACIFIC BIOSCIENCES OF ... Case No. CIV509210 SUMMARY NOTICE OF PROPOSED SETTLEMENT OF CLASS ACTION Hon. ...
... , This news release is available in ... findings are reported in the current issue of the " Journal ... The body,s repair mechanisms begin to fail with increasing age. As ... for many diseases, including Alzheimer,s disease, diabetes, cardiovascular disorders and cancer, ...
... 25, 2013 Developing ways to treat cancer patients with drugs ... effects is one of the topics in the premiere segment ... the American Chemical Society (ACS), the world,s largest scientific society. ... on DVD . Titled Prized Science: ...
Cached Biology News:Robbins Geller Rudman & Dowd LLP and Scott+Scott, Attorneys at Law, LLP Announce Proposed Settlement of Class Action in the Pacific Biosciences Securities Litigation 2Robbins Geller Rudman & Dowd LLP and Scott+Scott, Attorneys at Law, LLP Announce Proposed Settlement of Class Action in the Pacific Biosciences Securities Litigation 3Robbins Geller Rudman & Dowd LLP and Scott+Scott, Attorneys at Law, LLP Announce Proposed Settlement of Class Action in the Pacific Biosciences Securities Litigation 4Rapamycin: Limited anti-aging effects 2Rapamycin: Limited anti-aging effects 3American Chemical Society launches 2013 edition of popular Prized Science video series 2
Human ULBP-3 MAb (Clone 166514)...
... ( Abpromise for all tested ... Synthetic peptide corresponding to amino acid ... of rat GRASP1, conjugated to keyhole ... Entrez GeneID: 56850 ...
BOND ELUT MATRIX-C18, 25 mg ...
(3-[125I]iodotyrosyl26)Galanin, porcine, 370 kBq, 10 uCi. Category: IODINE LIGANDS....
Biology Products: